Cargando…

Epidemiological Survey of Different Treatments for Choledocholithiasis in Taiwan: A Nationwide, Population-Based Cohort Analysis

(1) Background: Open, laparoscopic, and endoscopic choledocholithotomy (OC, LC, and EC, respectively) are accepted choledocholithiasis treatment modalities. However, an assessment of the nationwide trends in their outcomes is lacking. This nationwide population-based analysis evaluated treatment out...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jia-Hui, Chung, Chi-Hsiang, Li, Chung-Hsien, Chien, Wu-Chien, Chang, Chao-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876383/
https://www.ncbi.nlm.nih.gov/pubmed/35207241
http://dx.doi.org/10.3390/jcm11040970
_version_ 1784658157522386944
author Chen, Jia-Hui
Chung, Chi-Hsiang
Li, Chung-Hsien
Chien, Wu-Chien
Chang, Chao-Feng
author_facet Chen, Jia-Hui
Chung, Chi-Hsiang
Li, Chung-Hsien
Chien, Wu-Chien
Chang, Chao-Feng
author_sort Chen, Jia-Hui
collection PubMed
description (1) Background: Open, laparoscopic, and endoscopic choledocholithotomy (OC, LC, and EC, respectively) are accepted choledocholithiasis treatment modalities. However, an assessment of the nationwide trends in their outcomes is lacking. This nationwide population-based analysis evaluated treatment outcomes of choledocholithiasis in Taiwan; (2) Methods: A total of 13,139,306 individuals were randomly enrolled from the Longitudinal Health Insurance Database (LHID) between 2000 to 2013 for cohort analysis. All patients with newly diagnosed choledocholithiasis aged 18 years or older who were treated during the study period were enrolled and allocated to the OC, LC, EC, or combined endoscopy and open choledocholithotomy (CEOC) groups. Age, readmission, retained stone, comorbidities, hospital stay, medical cost, complications, mortality were analyzed; (3) Results: A total of 58,064 individuals met the inclusion criteria, including 46.54%, 1.10%, 47.52%, and 4.85% who underwent OC, LC, EC, and CEOC, respectively. The endpoint characteristics showed that the LC group had higher readmission, longer hospital stay, and higher medical cost. Cox regression analysis showed that the adjusted hazard ratio (HR) of complications for EC was 1.259 times higher than that for OC. The adjusted HRs of readmission within 90 days for LC, EC, and CEOC were higher than that of OC. The adjusted HR of retreatment with surgery was higher in LC. The adjusted HR of retreatment with endoscopy was higher in CEOC. The adjusted HR of mortality in EC was 1.603 times that of OC; (4) Conclusions: Different choledocholithiasis treatments lead to different outcomes. However, further studies on other large or national data sets are required to support these findings.
format Online
Article
Text
id pubmed-8876383
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88763832022-02-26 Epidemiological Survey of Different Treatments for Choledocholithiasis in Taiwan: A Nationwide, Population-Based Cohort Analysis Chen, Jia-Hui Chung, Chi-Hsiang Li, Chung-Hsien Chien, Wu-Chien Chang, Chao-Feng J Clin Med Article (1) Background: Open, laparoscopic, and endoscopic choledocholithotomy (OC, LC, and EC, respectively) are accepted choledocholithiasis treatment modalities. However, an assessment of the nationwide trends in their outcomes is lacking. This nationwide population-based analysis evaluated treatment outcomes of choledocholithiasis in Taiwan; (2) Methods: A total of 13,139,306 individuals were randomly enrolled from the Longitudinal Health Insurance Database (LHID) between 2000 to 2013 for cohort analysis. All patients with newly diagnosed choledocholithiasis aged 18 years or older who were treated during the study period were enrolled and allocated to the OC, LC, EC, or combined endoscopy and open choledocholithotomy (CEOC) groups. Age, readmission, retained stone, comorbidities, hospital stay, medical cost, complications, mortality were analyzed; (3) Results: A total of 58,064 individuals met the inclusion criteria, including 46.54%, 1.10%, 47.52%, and 4.85% who underwent OC, LC, EC, and CEOC, respectively. The endpoint characteristics showed that the LC group had higher readmission, longer hospital stay, and higher medical cost. Cox regression analysis showed that the adjusted hazard ratio (HR) of complications for EC was 1.259 times higher than that for OC. The adjusted HRs of readmission within 90 days for LC, EC, and CEOC were higher than that of OC. The adjusted HR of retreatment with surgery was higher in LC. The adjusted HR of retreatment with endoscopy was higher in CEOC. The adjusted HR of mortality in EC was 1.603 times that of OC; (4) Conclusions: Different choledocholithiasis treatments lead to different outcomes. However, further studies on other large or national data sets are required to support these findings. MDPI 2022-02-12 /pmc/articles/PMC8876383/ /pubmed/35207241 http://dx.doi.org/10.3390/jcm11040970 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chen, Jia-Hui
Chung, Chi-Hsiang
Li, Chung-Hsien
Chien, Wu-Chien
Chang, Chao-Feng
Epidemiological Survey of Different Treatments for Choledocholithiasis in Taiwan: A Nationwide, Population-Based Cohort Analysis
title Epidemiological Survey of Different Treatments for Choledocholithiasis in Taiwan: A Nationwide, Population-Based Cohort Analysis
title_full Epidemiological Survey of Different Treatments for Choledocholithiasis in Taiwan: A Nationwide, Population-Based Cohort Analysis
title_fullStr Epidemiological Survey of Different Treatments for Choledocholithiasis in Taiwan: A Nationwide, Population-Based Cohort Analysis
title_full_unstemmed Epidemiological Survey of Different Treatments for Choledocholithiasis in Taiwan: A Nationwide, Population-Based Cohort Analysis
title_short Epidemiological Survey of Different Treatments for Choledocholithiasis in Taiwan: A Nationwide, Population-Based Cohort Analysis
title_sort epidemiological survey of different treatments for choledocholithiasis in taiwan: a nationwide, population-based cohort analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876383/
https://www.ncbi.nlm.nih.gov/pubmed/35207241
http://dx.doi.org/10.3390/jcm11040970
work_keys_str_mv AT chenjiahui epidemiologicalsurveyofdifferenttreatmentsforcholedocholithiasisintaiwananationwidepopulationbasedcohortanalysis
AT chungchihsiang epidemiologicalsurveyofdifferenttreatmentsforcholedocholithiasisintaiwananationwidepopulationbasedcohortanalysis
AT lichunghsien epidemiologicalsurveyofdifferenttreatmentsforcholedocholithiasisintaiwananationwidepopulationbasedcohortanalysis
AT chienwuchien epidemiologicalsurveyofdifferenttreatmentsforcholedocholithiasisintaiwananationwidepopulationbasedcohortanalysis
AT changchaofeng epidemiologicalsurveyofdifferenttreatmentsforcholedocholithiasisintaiwananationwidepopulationbasedcohortanalysis